OR WAIT null SECS
June 09, 2023
Jim Kremidas, former executive director, Association of Clinical Research Professionals, shares his experiences as a patient in clinical trials.
May 18, 2023
Even with exciting advancements, stakeholders must remain diligent in choosing data platforms.
April 17, 2023
Through grassroots patient education, local pharmacies serve as a pivotal doorway to improving access to trials.
March 03, 2023
The responsibility of increasing diversity falls on every stakeholder in the clinical trial value chain.
February 03, 2023
DCTs and RWD among topics for industry to focus on moving into 2023.
October 25, 2022
Study shows more support is needed for clinical teams to ‘FAIRify’ their data.
September 16, 2022
Accelerating trends in clinical data are forcing changes in strategy.
September 07, 2022
COVID spotlights the troubling disparity in clinical research representation. How can we remove these barriers?
August 11, 2022
How the digital environment can transform drug development space.
June 01, 2020
The only way for pharma companies to know where to focus their COVID-19 R&D efforts is for the industry to have access to real-time, real-world evidence of what’s working to keep people alive, write Travis Leonardi and William Kirsh.